| Type | Typical appearance | Clinical significance |
|---|---|---|
| Arterial | Bright red, pulsatile/spurting, high pressure | Rapid blood loss; urgent pressure, tourniquet, surgical or endovascular control |
| Venous | Dark red, steady/free flow, lower pressure | Can still be massive; pressure, ligation, suturing, packing |
| Capillary | Slow diffuse oozing from wound surface | Usually controlled with pressure, dressing, topical agents, coagulation correction |
| Class | Blood loss | Pulse | Respiratory rate | Typical clinical picture |
|---|---|---|---|---|
| I | < 15% < 750 ml |
< 100/min | 14-20/min | Minimal symptoms, normal BP, anxiety possible |
| II | 15-30% 750-1500 ml |
> 100/min | 20-30/min | Tachycardia, anxiety, narrowed pulse pressure, delayed capillary refill |
| III | 30-40% 1500-2000 ml |
> 120/min | 30-40/min | Hypotension, confusion, oliguria, shock; blood transfusion usually needed |
| IV | > 40% > 2000 ml |
> 140/min | > 35/min | Severe shock, lethargy/unconsciousness, life-threatening; massive transfusion/source control |
| Product | Main content | Main use |
|---|---|---|
| Whole blood | RBCs + plasma + platelets | Selected trauma/massive hemorrhage settings where available |
| Packed RBCs / PRBC | Red blood cells; about 250-300 ml/unit depending on preparation | Increase oxygen-carrying capacity in anemia/blood loss |
| Fresh frozen plasma / FFP | Coagulation factors | Coagulopathy with bleeding, massive transfusion, liver failure bleeding, warfarin reversal if PCC unavailable/adjunct |
| Platelets | Platelet concentrate | Thrombocytopenia or platelet dysfunction with bleeding/procedures; often target > 50,000/microliter for major surgery |
| Cryoprecipitate | Fibrinogen, factor VIII, factor XIII, vWF, fibronectin | Hypofibrinogenemia, DIC/major bleeding, massive transfusion |
| Fibrinogen concentrate / PCC | Specific factor concentrates | Targeted correction of fibrinogen deficiency or VKA-related coagulopathy according to protocol |